163 related articles for article (PubMed ID: 2204973)
1. Cancer of the cervix.
Thompson LJ
Semin Oncol Nurs; 1990 Aug; 6(3):190-7. PubMed ID: 2204973
[TBL] [Abstract][Full Text] [Related]
2. Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer.
Potter ME; Alvarez RD; Gay FL; Shingleton HM; Soong SJ; Hatch KD
Gynecol Oncol; 1990 Apr; 37(1):74-7. PubMed ID: 2323616
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
Gadducci A; Landoni F; Cosio S; Zizioli V; Zola P; Ferrero AM; Lapresa MT; Maggino T; Sartori E
Anticancer Res; 2018 Jun; 38(6):3627-3634. PubMed ID: 29848719
[TBL] [Abstract][Full Text] [Related]
4. [To reduce uncontrolled and recurrent cervical cancer].
Cao ZY
Zhonghua Fu Chan Ke Za Zhi; 2013 Apr; 48(4):302-3. PubMed ID: 23902817
[No Abstract] [Full Text] [Related]
5. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic indications in cancer of the uterine cervix].
Michel G; Lacour J
Maroc Med; 1972 Nov; 52(562):621-31. PubMed ID: 4665021
[No Abstract] [Full Text] [Related]
7. [Evaluation and treatment of cervical cancer].
Morice P; Haie-Meder C; Lhommé C
Rev Prat; 2001 Sep; 51(13):1432-8. PubMed ID: 11601072
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
[No Abstract] [Full Text] [Related]
9. A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy.
Wertheim MS; Hakes TB; Daghestani AN; Nori D; Smith DH; Lewis JL
J Clin Oncol; 1985 Jul; 3(7):912-6. PubMed ID: 2410573
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of locally advanced and recurrent cervical carcinoma: overview on current standard and new developments.
Höckel M
Onkologie; 2003 Oct; 26(5):452-5. PubMed ID: 14605461
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of stage I and II uterine cervix cancer. Round table].
Dargent D; Durand JC; Michel G; Pourquier H; Rudigoz RC; Senèze J
Rev Fr Gynecol Obstet; 1985 Apr; 80(5):299-322. PubMed ID: 4023538
[No Abstract] [Full Text] [Related]
12. Regarding a series of IB bulky cervical cancer treated with neoadjuvant chemotherapy (NACT) and radical hysterectomy and pelvic lymphadenectomy.
Bolis G; Villa A; Guarnerio P; Acerboni S; Parazzini F
Gynecol Oncol; 1996 Apr; 61(1):156-8. PubMed ID: 8626108
[No Abstract] [Full Text] [Related]
13. State-of-the-Art Treatment and Novel Agents in Local and Distant Recurrences of Cervical Cancer.
Tempfer CB; Beckmann MW
Oncol Res Treat; 2016; 39(9):525-33. PubMed ID: 27614445
[TBL] [Abstract][Full Text] [Related]
14. Evaluation and therapy of carcinoma of the uterine cervix.
van Nagell JR; Donaldson ES; Hanson MB
Curr Probl Cancer; 1983 Nov; 8(5):1-41. PubMed ID: 6357639
[No Abstract] [Full Text] [Related]
15. Glassy cell carcinoma of the uterine cervix: combination chemotherapy with paclitaxel and carboplatin in recurrent tumor.
Matsuura Y; Murakami N; Nagashio E; Toki N; Kashimura M
J Obstet Gynaecol Res; 2001 Jun; 27(3):129-32. PubMed ID: 11561828
[TBL] [Abstract][Full Text] [Related]
16. High-risk group for locoregional recurrence in patients with stage IB-IIB squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
Hirakawa M; Nagai Y; Toita T; Kudaka W; Inamine M; Ogawa K; Murayama S; Aoki Y
Anticancer Res; 2011 Apr; 31(4):1437-41. PubMed ID: 21508399
[TBL] [Abstract][Full Text] [Related]
17. Occult invasive cervical cancer found after inadvertent simple hysterectomy: is the ideal management: systematic parametrectomy with or without radiotherapy or radiotherapy only?
Narducci F; Merlot B; Bresson L; Katdare N; Le Tinier F; Cordoba A; Fournier C; Leblanc E
Ann Surg Oncol; 2015 Apr; 22(4):1349-52. PubMed ID: 25297903
[TBL] [Abstract][Full Text] [Related]
18. Effects of Neoadjuvant Chemotherapy Plus Radical Surgery as Front Line Treatment Strategy in Patients Affected by FIGO Stage III Cervical Cancer.
Di Donato V; Schiavi MC; Ruscito I; Visentin VS; Palaia I; Marchetti C; Fischetti M; Monti M; Muzii L; Benedetti Panici P
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):841-849. PubMed ID: 27678502
[TBL] [Abstract][Full Text] [Related]
19. Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery.
Ferrandina G; Margariti PA; Smaniotto D; Petrillo M; Salerno MG; Fagotti A; Macchia G; Morganti AG; Cellini N; Scambia G
Gynecol Oncol; 2010 Dec; 119(3):404-10. PubMed ID: 20817228
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of recurrent cervical cancer].
Sekiba K; Hayase R
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1839-42. PubMed ID: 2393303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
